Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
13.30
-0.04 (-0.30%)
Jul 20, 2026, 10:31 AM EDT - Market open

Kazia Therapeutics Revenue

In the fiscal year ending June 30, 2025, Kazia Therapeutics had annual revenue of 41.77K AUD, down -98.19%.

Revenue (ttm)
41.77K AUD
Revenue Growth
-98.19%
P/S Ratio
120.37
Revenue / Employee
6,961 AUD
Employees
6
Market Cap
151.98M USD

Revenue Chart

Chart
* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202541.77K-2.27M-98.19%
Jun 30, 20242.31M--
Jun 30, 2023---
Jun 30, 2022---
Jun 30, 202115.18M--
Jun 30, 2020---
Jun 30, 2019---
Jun 30, 2018119.00K-130.00K-52.21%
Jun 30, 2017249.00K-157.00K-38.67%
Jun 30, 2016406.00K317.00K356.18%
Jun 30, 201589.00K2.00K2.30%
Jun 30, 201487.00K-1.03M-92.18%
Jun 30, 20131.11M-335.00K-23.15%
Jun 30, 20121.45M-578.00K-28.54%
Jun 30, 20112.03M241.00K13.51%
Jun 30, 20101.78M-720.00K-28.75%
Jun 30, 20092.50M-10.78M-81.15%
Jun 30, 200813.28M-4.01M-23.20%
Jun 30, 200717.30M-150.00K-0.86%
Jun 30, 200617.45M56.00K0.32%
Jun 30, 200517.39M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LENZ Therapeutics20.99M
Pyxis Oncology13.86M
Caribou Biosciences11.20M
Innate Pharma10.57M
Milestone Pharmaceuticals1.78M
Molecular Partners AG856.30K
Connect Biopharma Holdings233.00K
Revenue Rankings

KZIA News

More News